Skip to main content
Erschienen in: Lung 5/2011

01.10.2011

Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters

verfasst von: D. Papakosta, G. Pitsiou, Z. Daniil, M. Dimadi, E. Stagaki, A. Rapti, K. Antoniou, A. Tzouvelekis, T. Kontakiotis, S. Tryfon, V. Polychronopoulos, D. Bouros

Erschienen in: Lung | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to prospectively evaluate the prevalence of pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF). One hundred thirty-nine patients (101 male, mean age = 68.6 ± 9 years), with confirmed IPF and who were admitted to eight Pulmonary Departments in Greece between November 2005 and December 2006 were included in the study. Pulmonary artery systolic pressure (PASP) was estimated by echocardiography, and PH was defined as PASP > 36 mmHg. We compared demographics, pulmonary function tests, NYHA functional status, 6-min walk distance (6MWD), B-type natriuretic peptide (BNP), PaO2, and P(A-a)O2 at rest data between patients with PH and without PH (PASP ≤ 36 mmHg). Increased estimated right ventricular systolic pressure was present in 55% of patients (mean PASP = 47.1 ± 11.2 mmHg vs. 30.3 ± 3.8 mmHg, respectively). Patients with PH had a lower but not statistically significant DLCO (47.1 ± 18.8 vs. 52.5 ± 20.1), lower PaO2 at rest (64.6 ± 12.2 vs. 71.1 ± 11.3, P = 0.004), and lower mean 6MWD (282 ± 118 vs. 338 ± 91, P = 0.007). Significant differences were also observed in the NYHA functional status between the two groups (P = 0.02). Statistically significant correlations were observed between PASP and PaO2 at rest (r = −0.331, P = 0.00), P(A-a)O2 at rest (r = 0.494, P = 0.00), 6MWD (r = −0.264, P = 0.01), SpO2 at rest (r = −0.293, P = 0.00), SpO2 at the end of exercise (r = −0.364, P = 0.00), and also BNP values (r = 0.319, P = 0.01). Moreover, PaO2 (P = 0.02), P(A-a)O2 (P = 0.005), and SpO2 at the end of exercise (P = 0.023) were independent predictors of the presence of estimated PH. Using Doppler echocardiography as a screening tool for the estimation of PH, we found that PH is common in patients with IPF. Gas exchange parameters at rest and exercise desaturation might indicate underlying PH in IPF.
Literatur
1.
Zurück zum Zitat Nathan SD, Noble PW, Tuder RM (2007) Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175:875–880PubMedCrossRef Nathan SD, Noble PW, Tuder RM (2007) Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175:875–880PubMedCrossRef
2.
Zurück zum Zitat King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164:1171–1181PubMed King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164:1171–1181PubMed
3.
Zurück zum Zitat Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:746–752PubMedCrossRef Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:746–752PubMedCrossRef
4.
Zurück zum Zitat Hamada K, Nagai S, Tanaka S et al (2007) Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131:650–656PubMedCrossRef Hamada K, Nagai S, Tanaka S et al (2007) Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131:650–656PubMedCrossRef
5.
Zurück zum Zitat Song JW, Song JK, Kim DS (2009) Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med 103:180–186PubMedCrossRef Song JW, Song JK, Kim DS (2009) Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med 103:180–186PubMedCrossRef
6.
Zurück zum Zitat Nadrous HF, Pellikka PA, Krowka MJ et al (2005) Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 128:2393–2399PubMedCrossRef Nadrous HF, Pellikka PA, Krowka MJ et al (2005) Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 128:2393–2399PubMedCrossRef
7.
Zurück zum Zitat Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD (2007) Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 131:657–663PubMedCrossRef Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD (2007) Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 131:657–663PubMedCrossRef
8.
Zurück zum Zitat Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 30:715–721PubMedCrossRef Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 30:715–721PubMedCrossRef
9.
Zurück zum Zitat Nathan SD, Shlobin OA, Ahmad S et al (2008) Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 76:288–294PubMedCrossRef Nathan SD, Shlobin OA, Ahmad S et al (2008) Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 76:288–294PubMedCrossRef
10.
Zurück zum Zitat Patel NM, Lederer DJ, Borczuk AC, Kawut SM (2007) Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 132:998–1006PubMedCrossRef Patel NM, Lederer DJ, Borczuk AC, Kawut SM (2007) Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 132:998–1006PubMedCrossRef
11.
Zurück zum Zitat Swanson KL, Utz JP, Krowka MJ (2008) Doppler echocardiography—right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit 14:CR177–CR182PubMed Swanson KL, Utz JP, Krowka MJ (2008) Doppler echocardiography—right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit 14:CR177–CR182PubMed
12.
Zurück zum Zitat American Thoracic Society/European Respiratory Society (2002) ATS/ERS International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304 American Thoracic Society/European Respiratory Society (2002) ATS/ERS International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304
13.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force et al (2005) Standarization of spirometry. Eur Respir J 26:319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force et al (2005) Standarization of spirometry. Eur Respir J 26:319–338PubMedCrossRef
14.
Zurück zum Zitat American Thoracic Society (2002) American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117 American Thoracic Society (2002) American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117
15.
Zurück zum Zitat Schiller NB (1991) Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 83(3 Suppl):1280–1287 Schiller NB (1991) Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 83(3 Suppl):1280–1287
16.
Zurück zum Zitat Schiller NB (1990) Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin 8:277–287PubMed Schiller NB (1990) Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin 8:277–287PubMed
17.
Zurück zum Zitat Task Force for Diagnosis and Treatment of Pulmonary Hypertension of ESC/ERS/ISHLT (2009) Guidelines on the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263CrossRef Task Force for Diagnosis and Treatment of Pulmonary Hypertension of ESC/ERS/ISHLT (2009) Guidelines on the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263CrossRef
18.
Zurück zum Zitat Morrison LK, Harrison A, Krishnaswamy P et al (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202–209PubMedCrossRef Morrison LK, Harrison A, Krishnaswamy P et al (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202–209PubMedCrossRef
19.
Zurück zum Zitat Flaherty KR, Andrei AC, Murray S et al (2006) Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 174:803–809PubMedCrossRef Flaherty KR, Andrei AC, Murray S et al (2006) Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 174:803–809PubMedCrossRef
20.
Zurück zum Zitat Kawut SM, O’Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM (2005) Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 99:1431–1439PubMedCrossRef Kawut SM, O’Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM (2005) Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 99:1431–1439PubMedCrossRef
21.
Zurück zum Zitat Gläser S, Noga O, Koch B et al (2009) Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 103:317–324PubMedCrossRef Gläser S, Noga O, Koch B et al (2009) Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 103:317–324PubMedCrossRef
22.
Zurück zum Zitat Papadopoulos CE, Pitsiou G, Karamitsos TD et al (2008) Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J 31:701–706PubMedCrossRef Papadopoulos CE, Pitsiou G, Karamitsos TD et al (2008) Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J 31:701–706PubMedCrossRef
23.
Zurück zum Zitat Leuchte HH, Neurohr C, Baumgartner RA et al (2004) Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 170:360–365PubMedCrossRef Leuchte HH, Neurohr C, Baumgartner RA et al (2004) Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 170:360–365PubMedCrossRef
24.
Zurück zum Zitat Leuchte HH, Baumgartner RA, Nounou ME et al (2006) Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 173:744–750PubMedCrossRef Leuchte HH, Baumgartner RA, Nounou ME et al (2006) Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 173:744–750PubMedCrossRef
25.
Zurück zum Zitat Behr J, Ryu JH (2008) Pulmonary hypertension in interstitial lung disease. Eur Respir J 31:1357–1367PubMedCrossRef Behr J, Ryu JH (2008) Pulmonary hypertension in interstitial lung disease. Eur Respir J 31:1357–1367PubMedCrossRef
26.
Zurück zum Zitat Nathan SD, Shlobin OA, Barnett SD et al (2008) Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 102:1305–1310PubMedCrossRef Nathan SD, Shlobin OA, Barnett SD et al (2008) Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 102:1305–1310PubMedCrossRef
27.
Zurück zum Zitat Zisman DA, Karlamangla AS, Kawut SM et al (2008) Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 133:640–645PubMedCrossRef Zisman DA, Karlamangla AS, Kawut SM et al (2008) Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 133:640–645PubMedCrossRef
28.
Zurück zum Zitat Zhang RF, Zhou L, Ma GF, Shao FC, Wu XH, Ying KJ (2010) Diagnostic value of transthoracic Doppler echocardiography in pulmonary hypertension: a meta-analysis. Am J Hypertens 23:1261–1264PubMedCrossRef Zhang RF, Zhou L, Ma GF, Shao FC, Wu XH, Ying KJ (2010) Diagnostic value of transthoracic Doppler echocardiography in pulmonary hypertension: a meta-analysis. Am J Hypertens 23:1261–1264PubMedCrossRef
29.
Zurück zum Zitat Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615–621PubMedCrossRef Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615–621PubMedCrossRef
Metadaten
Titel
Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters
verfasst von
D. Papakosta
G. Pitsiou
Z. Daniil
M. Dimadi
E. Stagaki
A. Rapti
K. Antoniou
A. Tzouvelekis
T. Kontakiotis
S. Tryfon
V. Polychronopoulos
D. Bouros
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 5/2011
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9304-5

Weitere Artikel der Ausgabe 5/2011

Lung 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.